<div id="readability-page-1"><div><ul> <li>Earlier this year, Greif reported a 24% year-over-year increase in adjusted EBITDA, driven by cost optimization, margin expansion, and reaffirmed 2026 guidance, while nearly completing a US$150,000,000 share repurchase program and authorizing an additional US$300,000,000 buyback.</li> <li>An interesting aspect for investors is management’s focus on organic growth initiatives and proprietary technologies such as its SIOC barrier solution, which sit alongside sizeable cash returns through ongoing share repurchases.</li> <li>Next, we’ll examine how Greif’s reaffirmed outlook and expanded share repurchase plan may influence the company’s existing investment narrative.</li> </ul><p>Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.</p><h2>Greif Investment Narrative Recap</h2><p>To own Greif today, you need to believe its mix of cost optimization, disciplined capital returns, and targeted growth projects can offset a muted industrial backdrop. The latest 24% year over year adjusted EBITDA increase supports that case, but the biggest near term catalyst remains management’s ability to sustain earnings quality as one off gains normalize, while the key risk is that ongoing demand softness in industrial and chemical end markets lingers. This news does not materially change those priorities.</p> <p>The expanded US$300,000,000 share repurchase authorization is particularly relevant here, because it sits alongside reaffirmed 2026 guidance and historically low leverage. For shareholders, that combination sharpens the focus on how much of Greif’s earnings resilience is being driven by structural improvements versus financial engineering, and how much flexibility the balance sheet retains if volumes in metals, fiber, and polymers stay weaker for longer than expected.</p> <p>Yet investors should be aware that intensifying competition and evolving packaging regulations could prove more important than they currently appear...</p> <p>Read the full narrative on Greif (it's free!)</p><p>Greif's narrative projects $4.5 billion revenue and $284.0 million earnings by 2029. This requires 1.5% yearly revenue growth and an earnings increase of about $97.5 million from $186.5 million today.</p><p>Uncover how Greif's forecasts yield a $78.20 fair value, a 22% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6adfc0be-7f92-4c6e-83e1-0f0cfa79593b/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6adfc0be-7f92-4c6e-83e1-0f0cfa79593b/chart/quote-price"/><figcaption>GEF 1-Year Stock Price Chart</figcaption></figure> <p>By contrast, the most bearish analysts were assuming revenue of about US$4.4 billion and earnings of roughly US$280.8 million by 2029, so if you worry that heavy buybacks could constrain flexibility, this new EBITDA strength may or may not be enough to shift that more pessimistic view once forecasts are updated.</p><p>Explore 5 other fair value estimates on Greif - why the stock might be worth over 3x more than the current price!</p><h2>The Verdict Is Yours</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your Greif research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.</li><li>Our free Greif research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Greif's overall financial health at a glance.</li></ul><h2>Curious About Other Options?</h2><p>Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:</p><ul><li>Find 49 companies with promising cash flow potential yet trading below their fair value.</li><li>The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</li><li>AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

<p>Greif reported a 24% year-over-year increase in adjusted EBITDA and announced a US$300 million share repurchase plan, reaffirming its 2026 guidance. The company's focus on cost optimization and organic growth initiatives aims to offset a muted industrial backdrop. While the expanded buyback may enhance shareholder value, risks include ongoing demand softness in key markets and intensifying competition. Analysts project Greif's revenue to reach $4.5 billion by 2029, with a fair value estimate of $78.20, indicating a potential 22% upside from its current price.</p>

Did Greif’s (GEF) Reaffirmed Outlook and Enlarged Buyback Just Shift Its Investment Narrative?